A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After NAC in TNBC (Apollo)
A Prospective, Phase II Trial Using Circulating Tumor DNA to Initiate Post-operation Boost Therapy After Neoadjuvant Chemotherapy in Triple-negative Breast Cancer
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Listed as NCT04501523, this PHASE2 trial focuses on Triple-negative Breast Cancer and remains actively recruiting participants. Sponsored by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, it has been updated 6 times since 2020, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2
-
Mar 2023 — Jul 2024 [monthly]
Recruiting PHASE2
-
Apr 2021 — Mar 2023 [monthly]
Recruiting PHASE2
-
Jan 2021 — Apr 2021 [monthly]
Recruiting PHASE2
▶ Show 1 earlier version
-
Sep 2020 — Jan 2021 [monthly]
Recruiting PHASE2
First recorded
Aug 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
For direct contact, visit the study record on ClinicalTrials.gov .